Endothelin-1 enhances cell migration through COX-2 up-regulation in human chondrosarcoma.

[1]  T. Yoneda,et al.  Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma. , 2012, International journal of oncology.

[2]  F. Tsai,et al.  Endothelin‐1 promotes MMP‐13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways , 2012, Journal of cellular physiology.

[3]  H. Hsieh,et al.  c-Src-dependent EGF receptor transactivation contributes to ET-1-induced COX-2 expression in brain microvascular endothelial cells , 2012, Journal of Neuroinflammation.

[4]  H. Kitagawa,et al.  Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum , 2012, Oncology reports.

[5]  Kanghua Li,et al.  Knockdown of endothelin A receptor expression inhibits osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse model. , 2012, Molecular medicine reports.

[6]  T. Maruyama,et al.  Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model , 2012, Laboratory Investigation.

[7]  Juan Cui,et al.  Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation , 2011, BMC Cancer.

[8]  Q. Liao,et al.  Endothelin-1 Promotes Osteosarcoma Cell Invasion and Survival against Cisplatin-induced Apoptosis , 2011, Clinical orthopaedics and related research.

[9]  G. Angelini,et al.  Endothelin-1 (ET-1) and vein graft failure and the therapeutic potential of ET-1 receptor antagonists. , 2011, Pharmacological research.

[10]  D. Theodorescu,et al.  Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer. , 2011, The Journal of clinical investigation.

[11]  V. Peinado,et al.  Endothelial progenitor cells undergo an endothelial-to-mesenchymal transition-like process mediated by TGFbetaRI. , 2010, Cardiovascular research.

[12]  D. Lu,et al.  Bradykinin‐induced cell migration and COX‐2 production mediated by the bradykinin B1 receptor in glioma cells , 2010, Journal of cellular biochemistry.

[13]  J. K. Kundu,et al.  Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling. , 2010, Cancer research.

[14]  L. Jeng,et al.  Cyclooxygenase-2 enhances α2β1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells , 2010, Molecular Cancer.

[15]  S. Watts.  Endothelin receptors: what's new and what do we need to know? , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[16]  P. Devillier,et al.  Expression of endothelin receptor subtypes in bronchial tumors. , 2009, Oncology reports.

[17]  L. Egevad,et al.  Endothelin-1 expression in prostate cancer and high grade prostatic intraepithelial neoplasia. , 2009, Analytical and quantitative cytology and histology.

[18]  Annamaria Biroccio,et al.  β-Arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invasion and metastasis , 2009, Proceedings of the National Academy of Sciences.

[19]  T. Tan,et al.  Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. , 2009, Carcinogenesis.

[20]  M. von Brandenstein,et al.  A p38-p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells. , 2008, Biochimica et biophysica acta.

[21]  F. Cunha,et al.  Endothelins modulate inflammatory reaction in zymosan‐induced arthritis: participation of LTB4, TNF‐α, and CXCL‐1 , 2008, Journal of leukocyte biology.

[22]  H. Leis,et al.  Endothelin (ET)‐1 and ET‐3 promote expression of c‐fos and c‐jun in human choriocarcinoma via ETB receptor‐mediated Gi‐ and Gq‐pathways and MAP kinase activation , 2008, British journal of pharmacology.

[23]  N. Rajeshkumar,et al.  Effect of the ETB Receptor Agonist, IRL-1620, on Paclitaxel Plasma Pharmacokinetics of Breast Tumor Rats , 2006, Experimental biology and medicine.

[24]  L. Hertle,et al.  The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications , 2006, Expert review of anticancer therapy.

[25]  F. Spinella,et al.  Emerging role of the endothelin axis in ovarian tumor progression. , 2005, Endocrine-related cancer.

[26]  K. Subbaramaiah,et al.  Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2* , 2005, Journal of Biological Chemistry.

[27]  Ching-Chow Chen,et al.  Akt Phosphorylation of p300 at Ser-1834 Is Essential for Its Histone Acetyltransferase and Transcriptional Activity , 2005, Molecular and Cellular Biology.

[28]  I. Stamenkovic,et al.  Endothelin Receptor B Inhibition Triggers Apoptosis and Enhances Angiogenesis in Melanomas , 2004, Cancer Research.

[29]  L. Kiesel,et al.  Endothelin-1-, Endothelin-A-, and Endothelin-B-Receptor Expression Is Correlated with Vascular Endothelial Growth Factor Expression and Angiogenesis in Breast Cancer , 2004, Clinical Cancer Research.

[30]  Hua-Lin Wu,et al.  Thrombomodulin-mediated Cell Adhesion , 2003, Journal of Biological Chemistry.

[31]  C. Shih,et al.  Damage formation and repair efficiency in the p53 gene of cell lines and blood lymphocytes assayed by multiplex long quantitative polymerase chain reaction. , 2003, Analytical biochemistry.

[32]  C. Hsieh,et al.  Differential gene expression of scopolamine-treated rat hippocampus-application of cDNA microarray technology. , 2003, Life sciences.

[33]  C. Tseng,et al.  Disabled‐2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells , 2003, FEBS letters.

[34]  K. Subbaramaiah,et al.  Cyclooxygenase 2: a molecular target for cancer prevention and treatment. , 2003, Trends in pharmacological sciences.

[35]  P. Lala,et al.  Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis , 2001, International journal of cancer.

[36]  H. Osada,et al.  Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis , 2001, Oncogene.

[37]  J. Dřímal,et al.  Enhanced endothelin ETB receptor down-regulation in human tumor cells , 2000 .

[38]  G. Schwartz,et al.  Chemotherapy and P‐glycoprotein expression in chondrosarcoma , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[39]  Y. Yatabe,et al.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.

[40]  D. Scollard,et al.  Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. , 1998, Journal of the National Cancer Institute.

[41]  M. Kondo,et al.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.

[42]  F. Staerman,et al.  Endothéline-1 et récepteur A : valeur pronostique pour la reprise évolutive biologique dans l’adénocarcinome de prostate localement avancé et métastatique ganglionnaire☆ , 2012 .

[43]  R. DuBois,et al.  Cyclooxygenase-2: a therapeutic target. , 2002, Annual review of medicine.